Mehmet Pisak;Mehmet Levent Selamoglu;Ibrahim Mustafa Iskender Pisak;Semra Bingol
发明人:
Ibrahim Mustafa Iskender Pisak,Semra Bingol,Mehmet Levent Selamoglu,Mehmet Pisak
申请号：
US13076590
公开号：
US20120252831A1
申请日:
2011.03.31
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Provided are compositions comprising opioid antagonists, such as naltrexone naloxone, or nalmefene, or their pharmaceutically acceptable salts, and methods for treating scleroderma, including systemic sclerosis, therewith.
